A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 11-13

  Shoae Hassani, Alireza ^a   Sharif, Shiva ^a,b   Verdi, Javad ^a,c,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; FINASTERIDE; NEUROSTEROID; PRASTERONE; TESTOSTERONE;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; EMBRYONAL CARCINOMA STEM CELL; HORMONE RESPONSE; MACROGLIA; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; PLURIPOTENT STEM CELL; TESTOSTERONE BLOOD LEVEL;

5-ALPHA REDUCTASE INHIBITORS; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL PROLIFERATION; FINASTERIDE; HUMANS; NEURONS;

EID: 78650177286     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.018     Document Type: Article

References (29)

1. Masters J.R. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2002, 2:315-319.
2. Martin G.R., Evans M.J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci USA 1975, 72:1441-1445.
3. Martin G.R. Teratocarcinomas as a model system for the study of embryogenesis and neoplasia. Cell 1975, 5:229-243.
4. Andrews P.W. Teratocarcinomas and human embryology: pluripotent human EC cell lines. APMIS 1998, 1:158-167.
5. Verheijen M.H.G., Defize L.H.K. Signals governing extra embryonic endoderm formation in the mouse: involvement of the type 1 parathyroid hormone-related peptide (PTHrP) receptor, p21 ras and cell adhesion molecules. Int J Dev Biol 1999, 43:711-721.
6. Skerjanc I.S. Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc Med 1999, 9:139-143.
7. Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978, 15:393-403.
8. Liu J., Solway K., Messing R.O. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 1998, 18:7768-7778.
9. Jones-Villeneuve E.M., McBurney M.W., Rogers K.A., Kalnins V.A. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol 1982, 94:253-262.
10. McBurney M.W., Jones-Villeneuve E.M.V., Edwards M.K.S., Anderson P.J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 1982, 299:165-167.
11. Suzuki M., Wright L.S., Marwah P., Lardy H.A., Svendsen C.N. Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci USA 2004, 101(9):3202-3207.
12. Williams R.H., Wilson J.D. Williams textbook of endocrinology 1998, Saunders Pub., Philadelphia.
13. Parker C.R., Azziz R. Adrenal androgen production in response to adrenocorticotropin infusions in men. Endocr Res 1996, 22(4):717-722.
14. Regelson W., Loria R. Dehydroepiandrosterone (DHEA), the mother steroid in immunological action. Aging Clock 1994, 719:553-563.
15. Hackbert L., Heiman J.R. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med 2002, 11(2):155-162.
16. Sinha-Hikim I., Roth S.M., Lee M.I., Bhasin S. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 2003, 285:197-205.
17. Bukovsky A., Caudle M.R., Svetlikova M. Steroid-mediated differentiation of neural/neuronal cells from epithelial ovarian precursors in vitro. Cell Cycle 2008, 7(22):3577-3583.
18. Spritzer M.D., Galea L.A. Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats. Dev Neurobiol 2007, 67(10):1321-1333.
19. Dušková M., Hill M., Hanus M., Matoušková M., Stárka L. Finasteride treatment and neuroactive steroid formation. Prague Med Rep 2009, 110(3):222-230.
20. Gupta V., Bhasin S., Guo W., et al. Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and pre-adipocytes. Mol Cell Endocrinol 2008, 296(1):32-40.
21. Ramirez E., Cabeza M., Bratoef E., et al. Synthesis and pharmacological evaluation of new progesterone esters as 5α-reductase inhibitors. Chem Pharm Bul 2005, 53(12):1515-1518.
22. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003, 144(11):5081-5088.
23. Hariman C., Varadhan L., Walker A., Varughese G. Testosterone replacement in the setting of finasteride therapy: a therapeutic dilemma. Endocrine 2010, 21:43.
24. Katznelson L., Rosenthal D.I., Rosol M.S., Anderson E.J., Hayden D.L., Schoenfeld D.A., et al. Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. Am J Roentgenol 1998, 170:423-427.
25. Snyder P.J., Peachey H., Berlin J.A., et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000, 85:2670-2677.
26. Wang C., Swerdloff R.S., Iranmanesh A., et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J Clin Endocrinol Metab 2000, 85:2839-2853.
27. De Pergola G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes Relat Metab Disord 2000, 24(2):59-63.
28. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 2003, 28(2):139-168.
29. Lee H.J., Teixeira J. Evidence of a role for androgens in embryonic stem cell function and differentiation. Endocrinology 2008, 149(1):3-4.